Preparation and immunogenicity and immunoprotection of Hib polysaccharide conjugate vaccine based on pneumococcal surface adhesive (PsaA).Methods PsaA gene recombinant protein (rPsaA) was prepared by genetic engineering, and then conjugated with Hib polysaccharide by amide condensation.The 3-week-old mice were immunized with this vaccine, and mice were inoculated with tetanus toxoid and haemophilus influenzae type B (Hib) polysaccharide conjugate vaccine (hib-tt) as controls and phosphate buffer (PBS) as blank controls.
This report contains market size and forecasts of COVID-19 Recombinant Protein Vaccine in Global, including the following market information:
Global COVID-19 Recombinant Protein Vaccine Market Size 2024-2030, ($ millions)
The global COVID-19 Recombinant Protein Vaccine market is projected to reach US$ million by 2029.
We surveyed the COVID-19 Recombinant Protein Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Recombinant Protein Vaccine Market, by Type, 2024-2030 ($ millions)
Global COVID-19 Recombinant Protein Vaccine Market Segment Percentages, by Type
Being Developed
Preclinical
Clinical I
Clinical II
Global COVID-19 Recombinant Protein Vaccine Market, by Application, 2024-2030 ($ millions)
Global COVID-19 Recombinant Protein Vaccine Market Segment Percentages, by Application
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other
Global COVID-19 Recombinant Protein Vaccine Market, By Region and Country, 2024-2030 ($ Millions)
Global COVID-19 Recombinant Protein Vaccine Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
GSK
Johnson & Johnson
Sanofi
Novavax
Pukang Biologic Technology
Clover Biopharmaceuticals
Suzhou Yuzhibo Biotechnology
